To extend this to a clinically relevant setting, A1-transduced (GFP-sorted) WT or OX40 KO CD8 T cells were adoptively transferred into syngeneic recipients that were subsequently injected s.c. with B16 tumor cells expressing OVA. Here, TNFRSF4 is linked to neoplasm.